RECENT NEWS
FierceBiotech  8 hrs ago  Comment 
The FDA wants more time to review the NDA for Exalgo, a pain drug to be sold by Mallinckrodt, and has extended the Prescription Drug User Fee Act date three months to Feb. 22, 2010. The FDA's decision comes after more information was submitted to...
PR Newswire  Nov 19  Comment 
NEW YORK, Nov. 19 /PRNewswire/ -- As the seasons change, another season of coughs and running noses is here. Here's more on preparing yourself. Listen to this report from Ortho-McNeil-Janssen Pharmaceuticals Inc. at:
PR Newswire  Nov 19  Comment 
FREMONT, Calif., Nov. 19 /PRNewswire/ -- Quark Pharmaceuticals, Inc., the leader in siRNA therapeutics in clinicals, announced today that four of its siRNA R&D platform based programs have met clinical development milestones; patient enrollment was
PR Newswire  Nov 19  Comment 
EMERYVILLE, Calif., Nov. 19 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has expanded its Phase 2 clinical study of a proprietary investigational triple-combination antiviral drug therapy for
PR Newswire  Nov 19  Comment 
SAN DIEGO, Nov. 19 /PRNewswire/ -- Accumetrics, Inc., developer of the VerifyNow System, the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 Test was one of multiple methods evaluated in
StreetInsider.com  Nov 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Piper+Jaffray+Upgrades+Myriad+Pharmaceuticals+%28MYRX%29+to+Neutral/5125272.html for the full story.
PR Newswire  Nov 18  Comment 
CLEVELAND, Nov. 18 /PRNewswire/ -- MyClyns, the new non-alcohol germ protection spray, is now available to consumers over the counter throughout Greater Cleveland, one of two cities in the nation chosen as initial test market cities prior to a
PR Newswire  Nov 18  Comment 
NEWTOWN SQUARE, Pa., Nov. 18 /PRNewswire/ -- A panel of osteoarthritis (OA) key opinion leaders has developed a consensus of the optimal exogenous hyaluronic acid (HA) treatment. This consensus was achieved by utilizing what the experts referred to
Marketwire  Nov 18  Comment 
CHAPEL HILL, NC and ORLANDO, FL -- (Marketwire) -- 11/18/09 -- Cardioxyl Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing therapies for the treatment of cardiovascular disease, this week announced results of pre-clinical
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 

This is a list of sub-industries in the pharmaceuticals industry, and a list of their member companies



Drug Delivery

Drug Manufacturers - Major

Drug Manufacturers - Other

Drug Related Products

Biotechnology

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki